Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 1.100
0.00 (0.00%)
Sep 24, 2026, 3:59 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 84.02 million as of September 24, 2026. Its market cap has decreased by -31.25% in one year.
Market Cap
84.02M
Enterprise Value
81.53M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
ChartMarket Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 84.02M, an increase of 795.37%. That is a compound annual growth rate of 7.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 84.02M | -53.59% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 126.06M |
| ME Therapeutics Holdings | 60.78M |
| NurExone Biologic | 59.77M |
| BriaCell Therapeutics | 52.37M |
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 40.41M |